Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation
NCT02541266 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207
Last updated 2020-01-28
Summary
This research is aimed at finding out what may influence the decision of patients to participate in trials involving imaging so that the investigators may improve our future studies so they are more patient focused and acceptable in regards to scan schedules.
Conditions
Interventions
- OTHER
-
Questionnaire
A short questionnaire (9 questions) will be given to the participants to complete.
Sponsors & Collaborators
-
National Institute for Health Research, United Kingdom
collaborator OTHER_GOV -
Royal Marsden NHS Foundation Trust
collaborator OTHER -
Institute of Cancer Research, United Kingdom
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-01
- Primary Completion
- 2018-08-01
- Completion
- 2018-08-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
NCT04252859 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
NCT00775957 ·Status: TERMINATED
-
Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
NCT01664936 ·Status: COMPLETED
-
Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer
NCT00005666 ·Status: COMPLETED ·Phase: NA
-
MRI Optimization Study in Stage III NSCLC
NCT02076282 ·Status: UNKNOWN
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
NCT00236275 ·Status: COMPLETED ·Phase: PHASE3
-
Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases
NCT04626206 ·Status: UNKNOWN
-
Positron Emission Tomography in Patients With Breast Cancer
NCT00001385 ·Status: COMPLETED
-
PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo
NCT04149353 ·Status: TERMINATED ·Phase: NA
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Brain Imaging Biomarkers in Patients With Brain Metastasis
NCT04197297 ·Status: RECRUITING ·Phase: PHASE2
-
18F-FSPG PET/CT for Cancer Patients on Therapy
NCT02599194 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2
-
FDG PET-CT for Lymphoma Radiotherapy Planning Version 1.3
NCT01999998 ·Status: UNKNOWN ·Phase: NA
-
Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer
NCT01621529 ·Status: COMPLETED
-
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
NCT04271436 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.
NCT00200668 ·Status: TERMINATED ·Phase: NA
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED
-
[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
NCT00832598 ·Status: COMPLETED ·Phase: NA
-
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
NCT01712815 ·Status: TERMINATED ·Phase: NA
-
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
NCT05524454 ·Status: COMPLETED ·Phase: NA